ReShape Lifesciences® Enters into Warrant Exercise Transaction for $1.2 Million in Gross Proceeds

<p>IRVINE, Calif., Nov. 21, 2023 (GLOBE NEWSWIRE) — ReShape Lifesciences, Inc. (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health solutions company, announced today that it has entered into a warrant exercise agreement with an existing accredited investor to exercise outstanding warrants to purchase an aggregate of 5,382,500 shares of the company’s common stock. In […]</p>
<p>The post <a href="https://forextv.com/top-news/reshape-lifesciences-enters-into-warrant-exercise-transaction-for-1-2-million-in-gross-proceeds/">ReShape Lifesciences® Enters into Warrant Exercise Transaction for $1.2 Million in Gross Proceeds</a> appeared first on <a href="https://forextv.com">ForexTV</a>.</p>